Business Context and Reporting Period
Empire Petroleum Corporation (NYSE American: EP) filed a Current Report on Form 8-K dated November 5, 2025. The filing details amendments to a material definitive agreement entered into on September 24, 2025, with Phil E. Mulacek regarding a promissory note and associated warrants.
Key Financial Metrics and Obligations
- Debt Instrument: Promissory Note with an aggregate principal amount of $4,000,000, due September 23, 2027, accruing interest at 5.5% per annum.
- Funding Status: As of September 25, 2025, $2,000,000 (the "First Advance") has been advanced. Up to an additional $2,000,000 may be advanced at the Company's request, subject to Mr. Mulacek's sole discretion.
- Conversion Terms (First Advance): Conversion price amended from $4.27 to $4.32 per share.
- Warrant Terms (First Advance): Warrant shares reduced from 281,030 to 138,889; exercise price amended from $4.27 to $4.32 per share.
- Additional Advance Terms: Future advances will have a conversion price based on the average official closing price of the five trading days preceding the advance. Additional warrants will be issued covering 30% of the advance amount divided by the conversion price.
- Dilution Cap: Total common stock issuable via conversions and warrant exercises is capped at 1,217,798 shares.
Material Changes Versus Prior Period
The filing reports a material amendment to the September 2025 Note and Warrant agreement via a Letter Agreement dated November 5, 2025. Key changes include:
- Discretionary Funding: The right to request additional advances was clarified to be subject to the lender's sole and absolute discretion.
- Price Adjustments: The conversion price and warrant exercise price for the initial $2,000,000 advance were increased from $4.27 to $4.32.
- Warrant Reduction: The number of warrant shares issued for the initial advance was reduced by approximately 50% (from 281,030 to 138,889).
- Future Pricing Mechanism: Established a floating conversion price for any future "Additional Advances" based on a 5-day average closing price, differing from the fixed price of the initial advance.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, revenue outlook, or management commentary on operational performance. The primary risk disclosed relates to the potential dilution of existing shareholders through the conversion of debt and exercise of warrants, capped at 1,217,798 shares. The filing references material relationships between the Company and Mr. Mulacek in prior filings (Proxy Statement, Form 8-K, and Form 10-Q).
Investor Verification Checklist
- Verify the current market price of EP stock relative to the new conversion/exercise price of $4.32 to assess immediate dilution risk.
- Review the referenced 2025 Proxy Statement and June 2025 Form 8-K to understand the full nature of the relationship with Phil E. Mulacek.
- Monitor future filings for any "Additional Advances" to determine the floating conversion price and resulting warrant issuance.
- Confirm the Company's liquidity position and ability to service the 5.5% interest on the outstanding $2,000,000 principal.